<DOC>
	<DOCNO>NCT01045447</DOCNO>
	<brief_summary>This trial conduct Africa , Asia , Europe United States America ( USA ) . The aim clinical trial compare NN5401 ( insulin degludec/insulin aspart ) insulin glargine patient type 2 diabetes inadequately control insulin oral anti-diabetic drug ( OADs ) . Subjects continue ongoing treatment OADs trial .</brief_summary>
	<brief_title>Comparison NN5401 With Insulin Glargine , Both Combination With Oral Antidiabetic Drugs , Subjects With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Hypoglycemic Agents</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Type 2 diabetes mellitus ( diagnose clinically ) least 6 month Treatment basal insulin regimen ( insulin detemir , insulin glargine neutral protamine Hagedorn [ NPH ] insulin ) daily ( OD ) , least 3 month Ongoing treatment : metformin without oral antidiabetic drug ( OADs ) least 3 month prior randomisation HbA1c 7.010.0 % ( inclusive ) central laboratory analysis BMI maximum 40.0 kg/m^2 Treatment insulin regimens basal insulin regimen ( insulin detemir insulin glargine NPH insulin ) OD within 3 month prior Visit 1 Treatment glucagonlike peptide 1 ( GLP1 ) receptor agonist within 3 month prior visit 1 Current rosiglitazone user Cardiovascular disease , within last 6 month prior visit 1 , define : stroke ; decompensated heart failure New York Heart Association ( NYHA ) class III IV ; myocardial infarction ; unstable angina pectoris ; coronary arterial bypass graft angioplasty Uncontrolled treated/untreated severe hypertension ( systolic blood pressure least 180 millimetre ( mm ) mercury ( Hg ) and/or diastolic blood pressure least 100 mmHg ) Impaired liver function , define alanine aminotransferase ( ALAT ) least 2.5 time upper limit normal ( one retest analyse central laboratory within week receipt result permit result last sample conclusive ) Pregnancy , breastfeeding , intention become pregnant use adequate contraceptive measure accord local requirement Cancer medical history cancer hereof ( except basal cell skin cancer squamous cell skin cancer )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>